Hyundai Pharm (004310) — Cash Flow Quality Index
Hyundai Pharm (004310) has a Cash Flow Quality Index of 0.45x as of February 2026. Operating cash flow of ₩188.28 Million is below net income of ₩420.00 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Hyundai Pharm operating cash flow efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Hyundai Pharm Cash Flow Quality Index (2010–2025)
Historical Cash Flow Quality Index for Hyundai Pharm across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Hyundai Pharm (004310) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Hyundai Pharm (2010–2025)
Year-by-year earnings quality comparison for Hyundai Pharm. For live market cap and the full company financial profile, see 004310 market cap overview.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -0.05x | ₩-123.29 Million | ₩2.52 Billion | ▲ +93.4% |
| 2023 | -0.74x | ₩-4.55 Billion | ₩6.12 Billion | ▼ -115.0% |
| 2020 | 4.94x | ₩10.80 Billion | ₩2.19 Billion | ▼ -17.8% |
| 2019 | 6.01x | ₩6.96 Billion | ₩1.16 Billion | ▲ +97.0% |
| 2018 | 3.05x | ₩2.83 Billion | ₩928.94 Million | ▲ +324.6% |
| 2017 | -1.36x | ₩-1.98 Billion | ₩1.46 Billion | ▲ +37.6% |
| 2016 | -2.18x | ₩-2.75 Billion | ₩1.26 Billion | ▼ -138.8% |
| 2013 | 5.62x | ₩7.95 Billion | ₩1.41 Billion | ▼ -53.4% |
| 2011 | 12.05x | ₩6.27 Billion | ₩520.10 Million | ▲ +1235.5% |
| 2010 | 0.90x | ₩2.68 Billion | ₩2.97 Billion | — |